{"name":"AgelessRx","slug":"agelessrx","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GSH","genericName":"GSH","slug":"gsh","indication":"Age-related oxidative stress and cellular dysfunction (investigational)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Invokana Pill","genericName":"Invokana Pill","slug":"invokana-pill","indication":"Type 2 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"GSH","genericName":"GSH","slug":"gsh","phase":"phase_3","mechanism":"GSH (glutathione) is an antioxidant tripeptide that replenishes cellular glutathione levels to reduce oxidative stress and support cellular defense mechanisms.","indications":["Age-related oxidative stress and cellular dysfunction (investigational)"],"catalyst":""},{"name":"Invokana Pill","genericName":"Invokana Pill","slug":"invokana-pill","phase":"marketed","mechanism":"Invokana (canagliflozin) inhibits sodium-glucose cotransporter 2 (SGLT2) in the kidney to increase urinary glucose excretion and lower blood glucose.","indications":["Type 2 diabetes mellitus","Reduction of cardiovascular death and hospitalization for heart failure in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxOUTFVNTNTT3JjZk1lVDNXaThPTXVqZnNOU19mYm95eUVfSktpcm0yZUJxOW9ndERYRWVKRVBvdXE0QXdXVHdiOFZqVEJLY2FNVXBvam56UzY1ZkJKbkJqeDhKNHk2X2U1eHpyYkQyNEhHZXQxZC1FMEVyWUN0QUd1Yk9xQXJoWG5FdE1TcXBYejZxN0V6eVljU253NDdmbUJQaWV0NlNYZ1BiY0xGNEhUdnA5emlFQVduN1l5QzlNc1pXWjZBck1tVXk5Zms5bm9UeWxlVFhCQXNjbnJHVEpaQUI5djlMVndvR0FidzJubnpZeXYyRExYNC1rYUFpTk1STU1adW12cGJzOGZ5OHJ3VllaSEp4d25QZGcyeWkzNHZQNllJS2VpNExUMFhJcE5XT0xB?oc=5","date":"2026-03-13","type":"pipeline","source":"GlobeNewswire","summary":"AgelessRx 2026: Longevity Telehealth Platform Overview — - GlobeNewswire","headline":"AgelessRx 2026: Longevity Telehealth Platform Overview —","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5PWTMwZEY0S2ZMTUQ4S0JsWm9fWU5SbzJyVUNHRXdhYk81RVlNZ1pkbmpENHdZeDJyaE9VSEJIY0hEeUc1RHdCbFd5SHg2QXRuRlBBcVgycFl4SHluaTRVeWlUR0dBTEtJV05OQ09lSTNiQQ?oc=5","date":"2025-12-09","type":"pipeline","source":"Everyday Health","summary":"10 Best Platforms for Obtaining NAD+ Online in 2026 - Everyday Health","headline":"10 Best Platforms for Obtaining NAD+ Online in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQRDF1N0Eya21vN2ZDWUFkS2J0dXg4d1VSWlhTcDdZdDI1bzhDRldMRU41SFdRX2w3elRTQnpUaVFIdlFMdmZBcnRSb0VRSkNyNXoyNkxpNExOWC1sdml1OE5NWkZmNkl4SlFoY3hsaGI5SldKZmd0OS1uUnZpaUY0UVZ6bw?oc=5","date":"2025-05-29","type":"pipeline","source":"Yahoo Finance","summary":"AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare - Yahoo Finance","headline":"AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5lTHZIMmFVZ1dpOUhnaGxhbklvM3dTSEZDWDE5NGM3NW1oWXJpQkRyX2dVOXh2cWlFWURFZ1BJYzFvRUlLQjQ2dThCaksxeXBjZ1NpWGhNTFZUeUR6VVNkQjhOLUlxQnY4aENocTdB?oc=5","date":"2025-02-07","type":"pipeline","source":"Woman's World","summary":"AgelessRX Prescribes GLP-1s With an Anti-Aging Focus - Woman's World","headline":"AgelessRX Prescribes GLP-1s With an Anti-Aging Focus - Woman's World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQYVc0VVVpQThuQ3g5Q3VMZW5KWFhpaG0tUlVCMFpFT21TV3BQMmdVSy12MnJUcC1nakxBR1c5d0dpOFN4Qk1kdlR0WGlfU1AxU0Q1OVJTZEc0cHU1RmtGdkdQVnRGeldxdHZyU0xTQW9YRVV5aFU4Z05rZVF4OXM3eVFNcEdob3hnR0RwdkNKRXM1SmpTcmE3VEliR1BFTmRzOWpYSmVYOHljNjBNMFBFaklhY2g?oc=5","date":"2022-07-14","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Chronic fatigue: it is time to take its treatment more seriously - The Pharmaceutical Journal","headline":"Chronic fatigue: it is time to take its treatment more seriously","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPUHU0TEZJb3ZNRU5CakJZTk5qalA2dzJ2anJITk4xOFZEWkFRXzY2d1dzMU9IRGw1X0pkTUN5TTdCVjRKVTNGYXY0enlJYXlJVW4ybGhZekV5THpsbG9JcnhSR1NTT3lnV2FzZGVfeUx4NGNuMlZHT25ZTWFoZy1zN0hObkwwVkFPS2c?oc=5","date":"2021-02-15","type":"pipeline","source":"Longevity.Technology","summary":"NAD+ and metformin: AgelessRx’s anti-aging platform - Longevity.Technology","headline":"NAD+ and metformin: AgelessRx’s anti-aging platform","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}